These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35491102)

  • 1. A method for the generation of pseudovirus particles bearing SARS coronavirus spike protein in high yields.
    Fujioka Y; Kashiwagi S; Yoshida A; Satoh AO; Fujioka M; Amano M; Yamauchi Y; Ohba Y
    Cell Struct Funct; 2022 Jun; 47(1):43-53. PubMed ID: 35491102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated by SARS coronavirus spike proteins.
    Fukushi S; Watanabe R; Taguchi F
    Methods Mol Biol; 2008; 454():331-8. PubMed ID: 19057867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein.
    Fukushi S; Mizutani T; Saijo M; Matsuyama S; Miyajima N; Taguchi F; Itamura S; Kurane I; Morikawa S
    J Gen Virol; 2005 Aug; 86(Pt 8):2269-2274. PubMed ID: 16033974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells.
    Xiong HL; Wu YT; Cao JL; Yang R; Liu YX; Ma J; Qiao XY; Yao XY; Zhang BH; Zhang YL; Hou WH; Shi Y; Xu JJ; Zhang L; Wang SJ; Fu BR; Yang T; Ge SX; Zhang J; Yuan Q; Huang BY; Li ZY; Zhang TY; Xia NS
    Emerg Microbes Infect; 2020 Dec; 9(1):2105-2113. PubMed ID: 32893735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudotyped Vesicular Stomatitis Virus-Severe Acute Respiratory Syndrome-Coronavirus-2 Spike for the Study of Variants, Vaccines, and Therapeutics Against Coronavirus Disease 2019.
    Salazar-García M; Acosta-Contreras S; Rodríguez-Martínez G; Cruz-Rangel A; Flores-Alanis A; Patiño-López G; Luna-Pineda VM
    Front Microbiol; 2021; 12():817200. PubMed ID: 35095820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus.
    Havranek KE; Jimenez AR; Acciani MD; Lay Mendoza MF; Reyes Ballista JM; Diaz DA; Brindley MA
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33353101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic Tail Truncation of SARS-CoV-2 Spike Protein Enhances Titer of Pseudotyped Vectors but Masks the Effect of the D614G Mutation.
    Chen HY; Huang C; Tian L; Huang X; Zhang C; Llewellyn GN; Rogers GL; Andresen K; O'Gorman MRG; Chen YW; Cannon PM
    J Virol; 2021 Oct; 95(22):e0096621. PubMed ID: 34495700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2.
    Nie J; Li Q; Wu J; Zhao C; Hao H; Liu H; Zhang L; Nie L; Qin H; Wang M; Lu Q; Li X; Sun Q; Liu J; Fan C; Huang W; Xu M; Wang Y
    Emerg Microbes Infect; 2020 Dec; 9(1):680-686. PubMed ID: 32207377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Neutralizing Antibodies Against Highly Pathogenic Coronaviruses: A Detailed Protocol for a Rapid Evaluation of Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudovirus-Based Assay.
    Almahboub SA; Algaissi A; Alfaleh MA; ElAssouli MZ; Hashem AM
    Front Microbiol; 2020; 11():2020. PubMed ID: 33013745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.
    Dieterle ME; Haslwanter D; Bortz RH; Wirchnianski AS; Lasso G; Vergnolle O; Abbasi SA; Fels JM; Laudermilch E; Florez C; Mengotto A; Kimmel D; Malonis RJ; Georgiev G; Quiroz J; Barnhill J; Pirofski LA; Daily JP; Dye JM; Lai JR; Herbert AS; Chandran K; Jangra RK
    Cell Host Microbe; 2020 Sep; 28(3):486-496.e6. PubMed ID: 32738193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector.
    Liang Z; Wu X; Wu J; Liu S; Tong J; Li T; Yu Y; Zhang L; Zhao C; Lu Q; Qin H; Nie J; Huang W; Wang Y
    Emerg Microbes Infect; 2023 Dec; 12(2):e2261566. PubMed ID: 37727107
    [No Abstract]   [Full Text] [Related]  

  • 13. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.
    Verma D; Church TM; Swaminathan S
    J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of a recombinant VSV-Vectored SARS-CoV vaccine induced robust immunity in rhesus monkeys after single-dose immunization.
    Shan D; Tang X; Liu R; Pan D; Wang X; Ge J; Wen Z; Bu Z
    Virol Sin; 2022 Apr; 37(2):248-255. PubMed ID: 35234625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector.
    Kapadia SU; Simon ID; Rose JK
    Virology; 2008 Jun; 376(1):165-72. PubMed ID: 18396306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.
    Lu M; Zhang Y; Dravid P; Li A; Zeng C; Kc M; Trivedi S; Sharma H; Chaiwatpongsakorn S; Zani A; Kenney A; Cai C; Ye C; Liang X; Qiu J; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Peeples ME; Kapoor A; Li J
    J Virol; 2021 Sep; 95(20):e0059221. PubMed ID: 34379509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells.
    Carpinteiro A; Gripp B; Hoffmann M; Pöhlmann S; Hoertel N; Edwards MJ; Kamler M; Kornhuber J; Becker KA; Gulbins E
    J Biol Chem; 2021; 296():100701. PubMed ID: 33895135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization.
    Wohlgemuth N; Whitt K; Cherry S; Kirkpatrick Roubidoux E; Lin CY; Allison KJ; Gowen A; Freiden P; Allen EK; ; Gaur AH; Estepp JH; Tang L; Mori T; Hijano DR; Hakim H; McGargill MA; Krammer F; Whitt MA; Wolf J; Thomas PG; Schultz-Cherry S
    Microbiol Spectr; 2021 Oct; 9(2):e0105921. PubMed ID: 34704832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein.
    Tani H; Kimura M; Tan L; Yoshida Y; Ozawa T; Kishi H; Fukushi S; Saijo M; Sano K; Suzuki T; Kawasuji H; Ueno A; Miyajima Y; Fukui Y; Sakamaki I; Yamamoto Y; Morinaga Y
    Virol J; 2021 Jan; 18(1):16. PubMed ID: 33435994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic surface-enhanced Raman scattering effect to distinguish live SARS-CoV-2 S pseudovirus.
    Sitjar J; Xu HZ; Liu CY; Wang JR; Liao JD; Tsai HP; Lee H; Liu BH; Chang CW
    Anal Chim Acta; 2022 Feb; 1193():339406. PubMed ID: 35058004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.